VIN References

1. Athavale R, Naik R, Godfrey KA, Cross P, Hatem MH, de Barros Lopes A. Vulvar intraepithelial neoplasia--the need for auditable measures of management. European Journal of Obstetrics, Gynecology, & Reproductive Biology. 2008;137(1):97-102.
2. Aynaud O, Buffet M, Roman P, Plantier F, Dupin N. Study of persistence and recurrence rates in 106 patients with condyloma and intraepithelial neoplasia after CO2 laser treatment.  European Journal of Dermatology. 2008;18(2):153-8.
3. Barr E, Sings HL. Prophylactic HPV vaccines: new interventions for cancer control. Vaccine. 2008;26(49):6244-57.
4. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006;55(No. RR-11):1-94.
5. Chafe W, Ferguson K, Wilkinson EJ. Vulvar intraepithelial neoplasia (VIN): principles of surgical therapy. Colposcopy and Gynecol Laser Surg. 1988;4(3):125-132.
6. Chafe W, Richards A, Morgan L, Wilkinson E. Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN). Gynecol Oncol. 1988;31:154-162.
7. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol. 1986 Aug;68(2):251-8.
8. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247-55.
9. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2000;93:824-42.
10. Jones RW, Rowan EM. Spontaneous regression of vulvar intraepithelial neoplasia 2-3. Obstet Gynecol. 2000;96:470-2.
11. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;197:1018-22.
12. Kennedy CM, Boardman LA. New approaches to external genital warts and vulvar intraepithelial neoplasia. Clinical Obstetrics & Gynecology. 2008;51(3):518-26.
13. Kuehn BM. CDC panel backs routine HPV vaccination. JAMA. 2006;296(6):640-1.
14. Le T, Menard C, Hicks-Boucher W, Hopkins L, Weberpals J, Fung-Kee-Fung M. Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecol Oncol. 2007;106:579-84.
15. Likes WM, Russell C, Tillmanns T.   Women's experiences with vulvar intraepithelial neoplasia.
16. JOGNN - Journal of Obstetric, Gynecologic, & Neonatal Nursing. 2008;37(6):640-6.
17. Maclean AB, Jones RW, Scurry J, Neill S.  Vulvar cancer and the need for awareness of precursor lesions. [Review] [16 refs]  Journal of Lower Genital Tract Disease. 2009;13(2):115-7.
18. Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double-blinded study. Gynecol Oncol. 2007;1-7:219-22.
19. McClurg D, Hagen S.  Quality of life issues following surgery for vulval cancer: a case report. Physiotherapy Research International. 2009;14(3):193-8.
20. Ordi J, Alejo M, Fuste V, Lloveras B, Del Pino M, Alonso I, Torne A.   HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. American Journal of Surgical Pathology. 2009;33(11):1659-65.
21. Pinto AP, Miron A, Yassin Y, Monte N, Woo TY, Mehra KK, Medeiros F, Crum CP.   Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Modern Pathology. 2010;23(3):404-12.
22. Polterauer S, Catharina Dressler A, Grimm C, Seebacher V, Tempfer C, Reinthaller A, Hefler L. Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3.   International Journal of Gynecological Pathology. 2009;28(6):559-62.
23. Reid R, Scalzi P. Genital warts and cervical cancer. VII. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1985 Nov 15;153(6):611-8.
24. Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Giuliano AR.   Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.   Cancer. 2008;113(10 Suppl):2865-72, 2008 Nov 15.  
25. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Lower Genital Tract Dis. 2006;10:161-9.
26. Shatz P, Bergeron C, Wilkinson EJ, Areseneau J, Ferenczy A. Vulvar intraepithelial neoplasia and skin appendage involvement. Obstet Gynecol. 1989 Nov;74(5):769-74.
27. Sillman F, Stanek A, Sedlis A, Rosenthal J, Lanks KW, Buchhagen D, Nicastri A, Boyce J. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol. 1984 Oct 1;150(3):300-8.
28. Stanley M. Chapter 17: Genital human papillomavirus infections-current and prospective therapies. J Natl Cancer Inst Monogr. 2003;31:117-24.
29. Terlou A, Blok LJ,  Helmerhorst TJ, van Beurden M.   Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ. [Review] [146 refs]  Acta Obstetricia et Gynecologica Scandinavica. 2010;89(6):741-8.
30. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers RL, Casparie M, Abma W, van Kempen LC, de Hullu JA.   Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. European Journal of Cancer. 2009;45(5):851-6.
31. van de Nieuwenhof HP, van Kempen LC, de Hullu JA, Bekkers RL, Bulten J. Melchers WJ, Massuger LF. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.   Cancer Epidemiology, Biomarkers & Prevention. 2009;18(7):2061-7.
32. van de Nieuwenhof HP, van der Avoort IA, Massuger LF, de Hullu JA. Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222.  Gynecologic Oncology. 2008;109(3):430-1; author reply 431.
33. van de Nieuwenhof HP. van der Avoort IA. de Hullu JA.   Review of squamous premalignant vulvar lesions. Critical Reviews in Oncology-Hematology. 200868(2):131-56.
34. van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Kagie MJ, Meijer CJ, Aaronson NK, Kleinjan A, Heijmans-Antonissen C, Zijlstra FJ, Burger MP, Helmerhorst TJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. New England Journal of Medicine. 2008;358(14):1465-73.
35. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3,322 published patients. Gynecol Onco.l 2005;97:645-51.
36. Villada IB.   Vaccination against HPV-16 for vulvar intraepithelial neoplasia. New England Journal of Medicine. 362(7):655-6; author reply 656, 2010 Feb 18.
37. Wilkinson EJ, Cook JC, Friedrich EG Jr, Massey, JK. Vulvar intraepithelial neoplasia: association with cigarette smoking. Colposcopy and Gynecol Laser Surg. 1988;4(3):153-159.